Fundamental dimension Equity attribute | ABVEPeer $0.0301▼-49.83% Cap $1.54MP/E -0.0x QuantScore30/100 | ABVEFLeader $0.045▲+15.38% Cap $2.30MP/E — QuantScore75/100 | ATPCPeer $1.40▼-1.76% Cap $1.40MP/E -1.2x QuantScore28/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
75/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 75/100 | — | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | — | 50/100 |
Growth Revenue / earnings growth & margins | 0/100 | — | 38/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | — | -1.2x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -3.1x | — | -0.6x |
Price / Sales | 0.0x | — | 1.3x |
Price / Free Cash Flow | 0.6x | — | -1.4x |
PEG ratio | 0.00 | — | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | — | 2 / 9 |
Altman Z-Score | -2.71 (Distress) | — | 0.38 (Distress) |
Total debt / equity | -2.54 | — | 0.00 |
Quick ratio | 0.3x | — | 8.4x |
Interest coverage | -5.5x | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -7.1% | — | +15.2% |
Net income growth YoY | -17.2% | — | +7.7% |
Gross margin (TTM) | -1.6% | — | 58.9% |
Operating margin (FY) | -11.4% | — | -213.7% |
FCF margin (FY) | 0.9% | — | -158.4% |
5. Trailing price performancePrice change over period |
1M return | -49.8% | +125.0% | -37.7% |
3M return | -94.0% | -25.0% | -43.3% |
6M return | -97.8% | -91.9% | -39.1% |
Year to date | -98.2% | -97.2% | -73.8% |
1Y return | -98.4% | -99.0% | -97.8% |
3Y return | -99.7% | -98.8% | -99.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $733.15 +2435608.4% upside | — — | $-69.97 -5115.5% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |